On January 3, 2026, Makati Medical Center switched on the red lights atop its building—an unmistakable signal that the ...

Circulating tumor DNA (ctDNA) is a blood test that looks for tiny pieces of cancer DNA released by dying cells, allowing ...

Meanwhile, mortality from other leading cancers is declining ...

Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high ...

He said AI is already being used in hematology analysers, histopathology, cytopathology, prostate biopsies, lung cancer, breast cancer, lymph node metastasis, and urine and fluid examinations, with ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Scientists at Duke-NUS Medical School and the National University Health System (NUHS), together with an international team ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

Genetic mutations, oxidative stress, smoking, oral bacteria, and age-related blood mutations have been identified as early ...

Clinicians agreed that advance care planning and symptom management improve outcomes and are a critical piece of cancer ...

Duke-NUS and NUHS scientists uncover a complex web of genetic, age-related and microbial factors that increase the risk of ...

The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...